Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

Bibliographic Details
Main Authors: Karlsson, C, Dahl, H, Lundin, J, Rossmann, E, Brytting, M, Mellstedt, H, Linde, A, Österborg, A
Format: Online
Language:English
Published: Nature Publishing Group 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255266/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255266/

Similar Items